Apr 212011
 

MRI Brain scanHigh-resolution magnetic resonance (MR) imaging studies have identified characteristic changes in brain structure — thinning of key cortical regions and reduced volume of structures such as the hippocampus — in persons with mild cognitive impairment, in individuals known to carry gene mutations that directly cause Alzheimer’s disease, and in diagnosed Alzheimer’s patients.

The current study, published in the Annals of Neurology, involved 87 cognitively normal older individuals and 32 patients diagnosed with mild Alzheimer’s (matched for age, gender and education) who had enrolled in the long-term Harvard Aging Brain Study. Participants underwent both high-resolution MR imaging of brain structure and PET scanning with PiB to detect amyloid plaques.

The results showed that those cognitively normal individuals who had amyloid plaques also had structural changes similar to but less pronounced than the neurodegenerative changes seen in the symptomatic patients. Structural changes were most evident in areas comprising what is called the default network, which is known to be affected early in the course of Alzheimer’s disease.

The study was well conducted, well controlled and used the latest techniques in brain imaging. This paper provides further evidence that amyloid deposition is occurring in the brain decades before the dementia stage begins, and in fact, even before cognitive impairment develops. It also supports the idea that the mechanism by which cognitive impairment and dementia arise is due to atrophy, or shrinkage, of the brain in selected areas as a consequence of beta-amyloid deposition.

*Becker et al, Beta-amyloid associated coritcal thinning in clinically normal elderly. Annals of Neurology, March 2011.

Michael S. Rafii, M.D., Ph.D.
Associate Medical Core Director, Alzheimer’s Disease Cooperative Study
This post originally appeared in Alzheimer’s Insights, an ADCS Blog.

Learn More

  2 Responses to “MR Study Shows That Amyloid Deposits Occur Years Before Diagnosis”

  1. How can this research be used to allow early diagnosis? To carry out MR imaging on the whole population would not be possible.

  2. long term, chronic observation of amyloid presence in cerebral cavern fluids is only partially useful…identifying the autoimmune properties of the cerebral spinal fluids (if there is such a beast at work in the nervous system, on the other side of the blood brain barrier) would certainly go a ways towards identifying triggering mechanisms enabling amyloid saturation levels to overwhelm cognative neuromuscular properties of symptomatic hosts…..
    absent of an understanding of fundamental process(es) leading to the overproduction of amyloid plaques(1-99) a dialysis machine specifically geared to filtering, extracting freelance amyloid strings from cerebral spinal fluids before they zip up and form barriers, should suffice to prolong life until the specific errant process(es) are identified and defined

 Leave a Reply

(required)

(required)

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Alz.org main site  |  Research  |  Advocacy  |  Care and support  |  Message boards  |  Disclaimer  |  Donate  |  Contact us  |  Sign up for e-news
© 2011 Alzheimer's Association | Blog Suffusion theme by Sayontan Sinha